WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of two new products in its Microbial Solutions portfolio: an updated ...
Researchers and therapeutic manufacturers have long relied on classical microbiological methods to check their samples and surfaces for microbial contamination, primarily using lengthy ...
James C. Foster, Chairman, President, and Chief Executive Officer of Charles River Laboratories, commented, “The acquisition of Celsis combines leading providers of endotoxin and bacterial testing and ...
New EndoScan-V™ endotoxin detection software and Celsis® automated detection platform for rapid sterility introduced to address unmet industry needs WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results